1. Home
  2. RCON vs VERU Comparison

RCON vs VERU Comparison

Compare RCON & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Recon Technology Ltd.

RCON

Recon Technology Ltd.

HOLD

Current Price

$1.24

Market Cap

41.3M

Sector

Energy

ML Signal

HOLD

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.48

Market Cap

40.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCON
VERU
Founded
2007
1971
Country
China
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.3M
40.6M
IPO Year
2009
1990

Fundamental Metrics

Financial Performance
Metric
RCON
VERU
Price
$1.24
$2.48
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$25.00
AVG Volume (30 Days)
20.1K
158.1K
Earning Date
10-14-2025
12-15-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,252,775.00
$16,886,419.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
337.24
52 Week Low
$1.13
$2.11
52 Week High
$7.16
$14.20

Technical Indicators

Market Signals
Indicator
RCON
VERU
Relative Strength Index (RSI) 40.57 38.01
Support Level $1.13 $2.11
Resistance Level $1.36 $2.53
Average True Range (ATR) 0.09 0.20
MACD 0.02 0.03
Stochastic Oscillator 61.29 46.67

Price Performance

Historical Comparison
RCON
VERU

About RCON Recon Technology Ltd.

Recon Technology Ltd provides automation systems, industrial equipment, and support services tailored for the oil and gas industry in China. The company's business spans key segments such as automation products and software, equipment and accessories, oilfield environmental protection, and platform outsourcing services. It generates the majority of its revenue by providing integrated automation services to Chinese petroleum companies at oilfields. Its key products and services include pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system. The company's operations are centered on servicing upstream clients throughout China, with some broader industrial automation solutions.

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Share on Social Networks: